LEN GETZ: Open Payments
NPI 1831172444 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 60 payments from 13 companies in 2025. Trend: 2023 $350 · 2024 $809 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $235 |
| ABBVIE INC. | 4 | $143 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| EVOKE PHARMA, INC. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Corium, LLC | 2 | $31 |
Products named: TRINTELLIX, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, SPRAVATO, Auvelity, GIMOTI.
Industry payments across TN — which companies pay providers there.
